July 2021 Issue Table Of Contents

From The Editor

• Is Government-Enabled IP Theft Ever A Good Thing?

Feature Articles

• How A First-Time CEO Transformed Retrophin Into Travere Therapeutics

CEO Corner

• Against All Odds: Advancing From R&D To Phase 3
• Capitalization, Coaching, And Clarity Are Keys To Success

Companies To Watch

• NervGen Pharma

Industry Research

• Preferred Provider Type By Clinical Research Phase

Inside The Industry

• How AI & ML Are Transforming Drug Discovery And Development
• The Collective Benefits Of A Collaborative CFO
• Biopharma Innovators — The Challenges And Opportunities
• Life Sciences Faces Big Growth & Challenges
• Coming Out Of Stealth Mode: What To Know And Do
• From Fusion Energy To Med Device … To Drug Developer?
• Closing The Health Leadership Gender Gap
• The Economy Of The Future Is In Women’s Health

Industry Leader

• Hiring For Talent, Not Geography
• Is The Advent Of Decentralized Clinical Trials A Blessing Or A Curse?

Leadership Lessons

• Teach The Mind By Inspiring The Heart

Ask The Board

• Could The New Way Of Working More Virtually Offer Opportunities To Break The Silo Mentality That Exists Within Organizations?
• Gallup Reported That Millennials Want A Workplace That Cares About Employees’ Wellbeing. How Will We Engage The Millennials To Carry On, Or Will They Be Able To Change Pharma Culture?
• What Is Your Opinion On The Practical Applications Of CRISPR Cas9 And Will We See A Commercial Application Of This Technology In The Next Decade?